FDA Approved: XERAVA — Original Application (Tetraphase Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Xerava (eravacycline) from Tetraphase Pharmaceuticals in an original application for the treatment of complicated intra-abdominal infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infection

Drugs mentioned

• XERAVA (eravacycline)

Snippet

ORIG AP for XERAVA (ERAVACYCLINE)